Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

15
Number of overlapping holdings
17.9%
% of WDNA's 90 holdings also in CANC
31.3%
% of CANC's 48 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in CANC |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 2.7% | 5.4% | 2.7% | |
BLUEPRINT MEDICINES CORP. | 2.6% | 2.9% | 2.6% | |
BRIDGEBIO PHARMA, INC. | 2.4% | 4.5% | 2.4% | |
AMGEN INC | 1.7% | 2.8% | 1.7% | |
NOVARTIS AG | 1.7% | 4.3% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CANC
NATERA INC | 3.7% | |
TWIST BIOSCIENCE CORP. | 3.3% | |
NOVOZYMES A/S-B SHARES | 2.9% | |
VERICEL CORPORATION | 2.6% | |
VERACYTE INC | 2.1% | |
AGIOS PHARMACEUTICALS INC | 1.9% | |
VERTEX PHARMACEUTICALS INC | 1.8% | |
UNITED THERAPEUTICS CORP | 1.7% | |
ALNYLAM PHARMACEUTICALS INC | 1.6% | |
LABCORP HOLDINGS | 1.5% |
WDNA Underweight Relative to CANC
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% | |
REVOLUTION MEDICINES, INC. | -5.0% | |
ASTRAZENECA PLC | -4.2% | |
NUVALENT, INC. CLASS A | -3.9% | |
SUMMIT THERAPEUTICS INC | -3.9% | |
EXELIXIS INC | -3.8% | |
MERUS N.V. | -3.2% | |
ZAI LAB LTD. UNSPONSORED ADR | -3.0% | |
DAIICHI SANKYO CO LTD | -2.9% | |
LEGEND BIOTECH CORPORATION SPONSORED | -2.8% |